a phase i study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis
Published 1 year ago • 71 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
1:01
phase i study of ruxolitinib plus abemaciclib for patients with myelofibrosis
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
6:44
how does jakafi® (ruxolitinib) work?
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:38
manifest: pelabresib in combination with ruxolitinib in myelofibrosis
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:34
pelabresib in myelofibrosis: the manifest trials
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:30
insights into the manifest-2 study
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
4:48
an insight into the management of cytopenias in mf
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
1:19
insights into a phase i/ia study of venetoclax, ixazomib and dexamethasone for r/r al amyloidosis
-
1:27
insights into the reveal trial: the efficacy of ruxolitinib for the treatment of patients with pv